Post-market surveillanceNeuropeptide
Compound 61449
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061449
Risk Class
MODERATE
Last Audit
Feb 14, 2108
Research Abstract
Neuropeptide candidate engineered for cellular repair initiatives with automated dossier coverage.
Compound 61449 is a neuropeptide asset inside neuropeptide innovation track initiatives, optimized for cellular repair and tissue regeneration.
The dossier currently sits in post-market surveillance with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061449 with updates logged 2108-02-14.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cellular repairTissue regeneration
Nomenclature
CX-61449Neuropeptide Program 61449
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061449
- [2] Operations Pulse • Neuropeptide innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61449